# A Randomized Controlled Trial Comparing the Effectiveness and Safety of Topical Tacrolimus 0.03% Versus Crisaborole 2% in Patients With Mild to Moderate Atopic Dermatitis Over 8 Weeks

> **NCT07519174** · NA · NOT_YET_RECRUITING · sponsor: **Foundation University Islamabad** · enrollment: 72 (estimated)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** Tacrolimus
- **DRUG:** Crisaborole 2% Top Oint

## Key facts

- **NCT ID:** NCT07519174
- **Lead sponsor:** Foundation University Islamabad
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2026-11-01
- **Final completion:** 2027-01-01
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2026-04-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07519174

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07519174, "A Randomized Controlled Trial Comparing the Effectiveness and Safety of Topical Tacrolimus 0.03% Versus Crisaborole 2% in Patients With Mild to Moderate Atopic Dermatitis Over 8 Weeks". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07519174. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*